CREB3L1 and thyroid gland carcinoma: IHC staining of CREB3L1 in an independent cohort of 234 thyroid cancer tissues showed that high expression of CREB3L1 was significantly correlated with shorter progression-free survival (P = 0.000229) (Fig. 1D).